ÌÅÄÈÖÈÍÑÊÈÅ ÊÎÌÏÜÞÒÅÐÍÛÅ ÑÈÑÒÅÌÛ


Ñïèñîê ëèòåðàòóðû

  1. G. Nigro et all. Latent heart failure in muscular diseases: diagnosis and treatment. Acta Cardiomyologica V, N.2, 1993, 181-190.
  2. Adzija D. et al - A prospective cardiological study in patients with progressive muscular dystrophy Duchenne type in Belgrade - Acta-Cardiomiologica- 1994-v.6/1 P.59-68:
  3. Bushby K.M.D. et al - The clinical, genetic and dystrophin characteristics of Becker muscular dystrophy - J.Neurol.-1993 -v.240-P.98-104
  4. Chenard A.A. et al - Ventricular arrhythmia in Duchenne muscular dystrophy: Prevalence, significance and prognosis – Neuromuscular-disord. - 1993 V.3/3 P.201-206.
  5. Comi G.P. et al – Clinical variability in Becker muscular dystrophy. Genetic, biochemical and immunohistochemical correlates - Brain 1992 - v. 117 - P.1-14.
  6. De Kermadec J.M. et al - Prevalence of left ventricular systolic dysfunction in Duchenne muscular dystrophy: An echocardiographic study - Am-heart-j. - 1994 V.127/3 P.618-623.
  7. Dubowitz V. – Therapeutic possibilities in Duchenne muscular dystrophy - In: Fukuyama Y. et al (eds.) Modern Perspectives of Child Neurology – The Japanese Society of Child Neurology-1990-P.281-286.
  8. Folkers K; Simonsen R Two successful double-blind trials with coenzyme Q- 10 (vitamin Q-10) on muscular dystrophies and neurogenic atrophies. Biochimica-et- Biophysica-Acta-Molecular-Basis-of-Disease. 1271/1 (281-286) 1995.
  9. Fukuyama Y. et al (eds.) Fetal and Perinatal Neurology.- Basel: Karger,1992 - P. 46-60.
  10. Ishikawa Y, Bach JR, Sarma RJ et al., Cardiovascular consideration in the management of neuromuscular disease. Seminars in neurology,15/1 (93-108) 1995.
  11. Kubo M. et al - Clinical significance of late potential in patients with Duchenne muscular dystrophy - Pediatr-cardiol - 1993 - v.14/4 P.214-219.
  12. Le-Thiet-Thanh; Nguyen-Thi-Man; Hori-S; Sewry-CA; Dubowitz-V; Morris-GE Characterization of genetic deletions in Becker muscular dystrophy using monoclonal antibodies against a deletion-prone region of dystrophin. Am-J-Med-Genet. 1995 Aug 28; 58(2).
  13. Lidov H.G.W. et al - Localization of dystrophin to postsynaptic regions of central nervous system cortical neurons - Nature - 1990 v. 348 - P.725-728.
  14. Lobzin V.S; Saikova L.A; Chukhlovina M.L, Pustozerov V.G. Òhe use of bemitil in patients with progressive muscular dystrophies Vrach-Delo. 1992 Apr(4): 85-7.
  15. Maeda M. et al – Cardiac dystrophin abnormalities in Becker muscular dystrophy assessed by endomyocardial biopsy - American-Heart-Journal.- 1995 V. 129/4 P.702-707.
  16. Maeda M; Nakao S; Miyazato H; et al. Cardiac involvement in Becker muscular dystrophy J-am-coll-cardiol. 22/7 (1927-1934) 1993.
  17. Miyai-I; Kang-J; Nozaki-S; Matsumura-T Alteration of atrial natriuretic peptide in progressive muscular dystrophy with congestive heart failure Rinsho- Shinkeigaku. 1992 Jun; 32(6): 588-92.
  18. Nigro G, Comi LI, Limongelli FM et al. Progressive study of x-linked progressive muscular dystrophy in Campania. Muscle Nerve 1983;6;253-62.
  19. Nigro-G; Politano-L; Nigro-V; Petretta-VR; Comi-LI Mutation of dystrophin gene and cardiomyopathy. Neuromuscul-Disord. 1994 Jul; 4(4): 371-9.
  20. Oldfors A. et al - Dilated cardipmyopathy and the dystrophin gene: An illustrated review - Br-heart-j.- 1994 V. 72/4 P. 344-348.
  21. Oldfors-A; Eriksson-BO; Kyllerman-M; Martinsson-T; ahlstrom-J Dilated cardiomyopathy and the dystrophin gene: an illustrated review. Br-Heart-J. 1994 Oct; 72(4): 344-8.
  22. Palmucci-L; Doriguzzi-C; Mongini-T; Chiado-Piat-L; Restagno-G; Carbonara-A; Paolillo-V Dilating cardiomyopathy as the expression of Xp21 Becker type muscular dystrophy. J-Neurol-Sci. 1992 Sep; 111(2): 218-21.
  23. Passos-Buenos M.R. et al - Different mosaicism frequencies for proximal and distal Duchenne muscular dystrophy mutations idicate diffewrence in etiology and reccurence risk - Am.J.Med.Genet.-1992 v.51 - P.1150-1155.
  24. Piccolo-G; Azan-G; Tonin-P; et al. Development of cardiomyopathy in female carriers of Duchenne and Becker muscular dystrophies. JAMA. 1996 May 1; 275(17): 1335-8.
  25. Pons-F; Robert-A; Fabbrizio-E; et al. Utrophin localization in normal and dystrophin-deficient heart. Circulation. 1994 Jul; 90(1): 369-74.
  26. Quinlivan-R; Ball-J; Dunckley-M; Thomas-DJ; Flinter-F; Morgan-Hughes-J Becker muscular dystrophy presenting with complete heart block in the sixth decade. J- Neurol. 1995 Jun; 242(6): 398-400.
  27. Quinlivan-RM; Dubowitz-V Cardiac transplantation in Becker muscular dystrophy. Neuromuscul-Disord. 1992; 2(3): 165-7.
  28. Rees W; Schuler S; Hummel M; Hetzer R - Heart transplantation in patients with muscular dystrophy associated with end-stage cardiomyopathy J-heart- lung-transplant. 12/5 (804-807) 1993.
  29. Reinolds MV, Bristow MR, Bush EW et al. Angiotensin-converting DD genotype in patients with ichaemic or idiopathic dilated cardiomyopathy. Lancet;1993;342;1073-5.
  30. Saito K.et al - Molecular genetic analysis of Duchenne/Becker muscular dystrophy families. In: Ñlin-neurol. - 1992.
  31. Saito K.et al - Molecular genetic analysis of Duchenne/Becker muscular dystrophy families. In: Y.Fukuyama et al (eds.) Fetal and Perinatal Neurology.- Basel: Karger,1992 - P. 46-60.
  32. Saito M. et al - Clinical feature and mechanism of cardiac failure in patients with Becker muscular dystrophy - Clin-neurol.- 1994 V.34/2 P.134-140.
  33. Saito-M; Kawai-H; Adachi-K; Akaike-M Clinical feature and mechanism of cardiac failure in patients with Becker muscular dystrophy Rinsho-Shinkeigaku. 1994 Feb; 34(2): 134-40.
  34. Siciliano-G; Fanin-M; Angelini-C; Pollina-LE; Miorin-M; Saad-FA; Freda- MP; Muratorio-A Prevalent cardiac involvement in dystrophin Becker type mutation. Neuromuscul-Disord. 1994 Jul; 4(4): 381-6.
  35. Takenaka A. et al - Discrepancy between systolic and diastolic dysfunction of the left ventricle in patients with Duchenne muscular dystrophy - Eur-heart-j. - 1993 V.14/5 P.669-676.
  36. Tamura T. et al - Evaluation of myocardial damage in Duchenne's muscular dystrophy with thallium-201 myocardial - Jpn-heart-j. 1993 V.34/1 P.51-61.
  37. Towbin JA, Heitmancik F, Brink P et al. X-linked dilated cardiomyopathy. Circulation,1993;87;1854-65.
  38. Uchino M. et al - Localization and characterization of dystrophin in the central nervous system of controls and patients with Duchenne muscular dystrophy - J.Neurol.Neurosurg.Psychiatr.-1994 - v.57 P.426-429
  39. Yanagisawa A. et al - The prevalence and prognostic significance of arrhythmias in Duchenne type muscular dystrophy - Am-Heart-J. 1992 Nov V.124(5) P. 1244-50
  40. Yasuda N. et al - The effect of parental age on rate of mutation in Duchenne muscular dystrophy - Am.J.Med.Genet.-1982 - v.13 -P.91-99
  41. Yu-Y; Yamabe-H; Fujita-H; Inoue-T; Yokota-Y; Nishio-H; Wada-H; Matsuo-M; Yokoyama-M Cardiac involvement in a family with Becker muscular dystrophy. Intern-Med. 1995 Sep; 34(9): 919-23
  42. Zatz M, Melo MS, Pasos-Bueno MR et al., Association of schizophrenia and Becker dystrophy... Am J Hum Genet 1991, 49 Suppl 1, 364.
  43. Ì-de-Visser; de-Voogt-WG; la-Riviere-GV The heart in Becker muscular dystrophy, facioscapulohumeral dystrophy, and Bethlem myopathy. Muscle-Nerve. 1992 May; 15(5): 591-6.


"Ìåäèöèíñêèå Êîìïüþòåðíûå Ñèñòåìû"
103460, Ìîñêâà, à/ÿ 58
Òåë.: (095) 532-89-85
Òåë./Ôàêñ: (095) 532-89-86
E-mail: common@mks.ru